Subscribe
People
4 min read

A Third CEO Change Hits Pet Food in Three Weeks

Dan Waters, the former CEO of Enjoy Life Foods, has been named chief executive of I and love and you, following the company's acquisition of Made by Nacho and the hiring of Bobby Flay as chief culinary officer. It's the third pet-food leadership change The Underbite has tracked in the past three weeks, all involving executives from outside the pet industry.

Written by
Roy Ben-Tzvi
Published on
August 6, 2026
A Third CEO Change Hits Pet Food in Three Weeks

Pet food's executive suite keeps turning over this summer. The natural-channel brand I and love and you added itself to the list this week, naming Dan Waters as chief executive just weeks after acquiring a rival cat food brand and hiring a celebrity chef.

I and love and you names Dan Waters as CEO

Waters has taken over as chief executive of I and love and you, the company said this week. He previously served as chief executive of Enjoy Life Foods and held chief marketing officer roles at Bel Brands across North America and Europe; his background also includes time at the chocolate brand Hu.

The appointment follows two moves the company made earlier this year: the acquisition of Made by Nacho, a culinary-focused cat food brand, and the addition of celebrity chef Bobby Flay as chief culinary officer. Michael Meyer, who had led the company as chief executive, moves into the chairman role.

The company says it has passed $100 million in annual retail sales and sells through more than 30,000 doors nationwide across natural, grocery, mass, and e-commerce channels. The natural pet food channel, once the exclusive province of independent brands like this one, has drawn increasing competition from mainstream players expanding upscale lines, raising the stakes for smaller companies trying to defend their shelf position.

Why leadership churn is hitting pet food brands now

This is the third pet-food leadership change The Underbite has tracked in roughly three weeks. Mars tapped a Coca-Cola executive to run its North American pet nutrition business in late July, and Phillips installed a grocery supply-chain veteran as chief executive just three months after its Central Garden distribution deal closed. All three moves share a theme: executives from outside the pet industry are being brought in to run pet food companies at a moment when growth increasingly depends on retail execution and supply chain discipline rather than product innovation alone.

Waters fits that pattern. His background is in consumer packaged goods marketing and brand turnarounds, not pet care specifically, and Enjoy Life Foods, the allergen-free snack brand he previously led, faced a problem similar to the one now facing his new employer: a loyal niche customer base that a larger, better-capitalized competitor could squeeze on price and distribution.

Some rough math helps size the operation Waters is inheriting. A little over $100 million in annual retail sales spread across more than 30,000 doors works out to roughly $3,300 in retail sales per door per year, on average, though actual sales almost certainly skew toward a smaller set of higher-volume locations. That's a modest per-door footprint next to national brands with tens of thousands more doors and deeper shelf commitments, and it's the kind of gap a new chief executive with large-CPG experience is typically brought in to close.

The timing lines up with consolidation pressure across the category. Agrolimen's purchase of Ollie and the string of private-equity deals moving through pet food distribution this summer both signal that independent brands without scale are becoming acquisition targets rather than long-term standalone players. A leadership change built around distribution and retail experience reads as a defensive move against that backdrop, not just a routine succession.

What Waters must prove in his first two quarters

The first real test will be whether the Made by Nacho deal and the Bobby Flay tie-in translate into shelf space gains rather than just marketing noise. Celebrity chef partnerships have a mixed record in pet food specifically: they generate press coverage quickly but don't always move a retail buyer's decision on which two or three natural brands get an end-cap.

Watch the door count over the next two quarters more than the revenue figure. Growing the retail footprint meaningfully beyond 30,000 doors without discounting into thinner margins would validate the bet that CPG-honed distribution experience was what the brand needed. If door count stalls while marketing spend rises around the Flay partnership, the Made by Nacho acquisition will look more like a cash-flow patch than the platform expansion the company is positioning it as.

Source: "I and love and you" via PR Newswire

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
GoodVets Buys WellHaven's 40 Hospitals, Ending Its De Novo-Only Era
Funding & M&A
5 min read

GoodVets Buys WellHaven's 40 Hospitals, Ending Its De Novo-Only Era

GoodVets is acquiring WellHaven Pet Health's network of more than 40 hospitals, growing its footprint from 75 to 116 locations. The deal marks a shift from the de novo strategy that defined the General Atlantic-backed platform's first decade toward the acquisition-led growth every other scaled vet consolidator already runs on.

Read article
Read article
Dechra's Oral Cancer Pill Targets the Dogs Chemo Never Reaches
Launches
5 min read

Dechra's Oral Cancer Pill Targets the Dogs Chemo Never Reaches

Dechra is commercially launching Laverdia, the first FDA-approved oral treatment for canine lymphoma, developed by Anivive and licensed to Dechra in 2022. The bet isn't on winning cases from oncology referral networks, but on treating the roughly 80% of diagnosed dogs who currently get no chemotherapy at all.

Read article
Read article
PetMeds Names New CEO, Rebuilds Board Amid Takeover Fight
People
5 min read

PetMeds Names New CEO, Rebuilds Board Amid Takeover Fight

PetMeds named Jeff Willard as its next CEO and added two new independent directors, including a Shake Shack executive as board chair, while a $3-a-share takeover bid from SilverCape Investments remains unanswered since June. None of the three new leaders has prior ties to the company, a signal the board is building outside credibility for whatever comes next.

Read article
View all articles